Form 4: Dentsply Sirona Executive Richard Rosenzweig Reports Changes in Beneficial Ownership

Sentiment:

SEC Form 4 Filing


Richard Rosenzweig, SVP, Corp Dev, GC & Secretary of Dentsply Sirona, reports acquisition of common stock and phantom stock due to dividends and participation in the Employee Stock Purchase Plan.

Summary

  • Richard Rosenzweig, a senior executive at Dentsply Sirona, filed a Form 4 detailing changes in his beneficial ownership of the company's securities.
  • On July 12, 2024, Rosenzweig acquired 287.985 shares of common stock through dividends on restricted stock units (RSUs).
  • These RSUs vest simultaneously with the underlying awards and convert to common stock on a 1:1 basis.
  • He also acquired 12.1397 shares of phantom stock due to accrued dividends under the Supplemental Executive Retirement Plan (SERP).
  • Additionally, Rosenzweig acquired 236 shares between January 1st and June 30, 2024, through the Dentsply Sirona Employee Stock Purchase Plan.
  • Following these transactions, Rosenzweig beneficially owns 55,941.043 shares of common stock.
  • Each share of phantom stock is economically equivalent to one share of common stock and becomes payable upon termination of employment.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The filing reflects routine transactions related to compensation and employee benefits, indicating standard corporate practices.

Positives

  • Executive participation in the Employee Stock Purchase Plan indicates confidence in the company's future.
  • Dividend accrual on RSUs and phantom stock increases executive alignment with shareholder interests.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Comparison to Industry Standards

  • Comparing Rosenzweig's stock ownership changes with those of executives at similar dental and medical device companies like Align Technology (ALGN) or Straumann Holding AG can provide context.
  • Monitoring insider transactions across the industry helps gauge overall sentiment and potential trends.

Stakeholder Impact

  • The filing provides transparency to shareholders regarding executive stock ownership.
  • Employee participation in the stock purchase plan can boost morale.

Key Dates

DateDescription
January 1, 2024 June 30, 2024Period during which shares were acquired under the Employee Stock Purchase Plan
July 12, 2024Date of the reported transactions (acquisition of common stock and phantom stock)
July 15, 2024Date of signature for the Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.